logo
ProjectForthcoming

Decoding NK Cell Licensing Through Programmable Nanoscale Clustering and Spatial Mapping

The status, timeline and source of this project. A free account opens every field.

Source: EU Funding & Tenders Portal

Natural killer (NK) cells are innate lymphocytes that kill tumor and virus-infected cells without prior sensitization, but clinical translation is hampered by limited mechanistic insight into how NKs attain durable functional competence or “licensing”. NK_LIC2CLUSTER_SR1 will determine whether nanoscale clustering geometry of inhibitory receptors encodes licensing — a mechanistic insight that coul

Status
Prospective
Sector
Education
Location
Portugal
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Decoding NK Cell Licensing Through Programmable Nanoscale Clustering and Spatial Mapping

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Decoding NK Cell Licensing Through Programmable Nanoscale Clustering and Spatial Mapping” is an infrastructure initiative in the Education sector, located in Portugal. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Natural killer (NK) cells are innate lymphocytes that kill tumor and virus-infected cells without prior sensitization, but clinical translation is hampered by limited mechanistic insight into how NKs attain durable functional competence or “licensing”. NK_LIC2CLUSTER_SR1 will determine whether nanoscale clustering geometry of inhibitory receptors encodes licensing — a mechanistic insight that could enable engineering NK cells with predictable, MHC-independent, potency. We will test whether ligand-independent clustering of the inhibitory receptor Ly49A recruits ITIM-associated phosphatases (e.g., SHP-1) and induces a licensing-like state in vivo, and whether quantitative nanoscale features (e.g. cluster size, density) form reproducible “licensing signatures” that predict NK competence across MHC haplotypes. AIM 1 (causation): CRISPR knock-in of a chemically inducible Ly49A fusion at the Ncr1 locus in primary murine NKs will allow rapid, reversible clustering with a dimeriser. Functional (IFN-γ, CD107a, cytotoxicity, persistence, homing, tumor clearance) and mechanistic (ITIM phosphorylation, SHP-1 recruitment) readouts will be assessed ex vivo and after adoptive transfer into MHC-defined hosts. AIM 2 (prediction & translation): Super-resolution imaging (SLML) and single-molecule mapping will quantify Ly49A and phospho-SHP-1 architectures across haplotypes. Spatial metrics will be integrated with functional data to derive reproducible licensing signatures and build predictive functional models. The fellowship provides structured training and open-science outputs to accelerate fellow independence and maximise research impact. Leveraging worldwide expertise from the host labs in NK immunology, synthetic receptor engineering, advanced imaging, and computational modelling, the project will establish receptor topology as a mechanistic code for NK licensing, define nanoscale “licensing signatures,” and enable translational MHC-unrestricted immunotherapies.

Location

Country

Portugal

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Education

Article published date

2026-09-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project